pantoprazole has been researched along with Acute Hepatic Failure in 2 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sandig, C | 1 |
| Flechtenmacher, C | 1 |
| Stremmel, W | 1 |
| Eisenbach, C | 1 |
| Yusoff, IF | 1 |
| Nairn, P | 1 |
| Morgan, CA | 1 |
2 other studies available for pantoprazole and Acute Hepatic Failure
| Article | Year |
|---|---|
Pantoprazole induces severe acute hepatitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Chemical and Drug Induced Liver Injury; Female; Humans; Liv | 2011 |
Multiple organ failure related to pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acidosis, Lactic; Acute Kidney Injury; Aged; Anti-Ulcer Age | 1999 |